OmarJawdatMD

Neurology • Kansas City, KS

Neuromuscular Medicine

Associate Professor

Join to view full profile

Dr. Jawdat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jawdat's full profile

Already have an account?

Office
Rainbow Blvd
# 3599
Kansas City, KS 66160
Phone+1 913-588-6970

Fax+1 913-588-0673

Summary

http://www.kumc.edu/school-of-medicine/neurology/faculty/omar-jawdat-md.html

Education & Training

University of Kansas School of MedicineFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
University of Kansas School of MedicineChief Residency, Neurology, 2012 - 2013
University of Kansas School of MedicineResidency, Neurology, 2009 - 2013
University of Baghdad College of MedicineClass of 2002

Certifications & Licensure

KS State Medical License 2012 - 2025
MO State Medical License 2021 - 2025
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Trial of Oxaloacetate in ALS Start of enrollment: 2020 Mar 17
Completed
Phase 1

Publications & Presentations

PubMed

80 citations
Pompe Disease: Literature Review and Case Series
Majed Dasouki, Omar Jawdat, Osama Almadhoun, Mamatha Pasnoor, April McVey
Neurologic Clinics. 2014-08-01
5 citations
Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets.
Jessica M. Sage, LaSharice Hall, April McVey, Richard J. Barohn, Jeffrey Statland
Journal of Visualized Experiments. 2020-02-10
177 citations
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric
The Lancet. Neurology. 2021-07-01

Journal Articles

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Richard J Barohn, Mamatha Pasnoor, Omar Jawdat, Mazen M Dimachkie, JAMA Neurology
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.
van den Berg LH1, Sorenson E2, Gronseth G2, Macklin EA2, Andrews J2, Baloh RH2, Benatar M2, Berry JD2, Chio A2, Corcia P2, Genge A2, Gubitz AK2, Lomen-Hoerth C2, McDer..., Neurology, 4/2019

Authored Content

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020

Press Mentions

KC Man Diagnosed with ALS Will Be Part of Highly Competitive Medical TrialApril 26th, 2021

External Links

University Biohttp://www.kumc.edu/school-of-medicine/neurology/faculty/omar-jawdat-md.html